NGM·Healthcare·$1.4B·#163 / 520 in Healthcare
STAA STAAR Surgical Company
57SPECULATIVE
CATEGORY BREAKDOWN
GROWTH0
QUALITY60
STABILITY97
VALUATION71
GOVERNANCE37
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-23.7%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
76.2%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
54 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
11.1%
91
< 25% strong
Price / Sales
Market cap relative to trailing revenue
4.9x
71
< 3x strong
Rule of 40
Growth rate plus operating margin
-43
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.8%
6
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+0.5%
97
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE STAA WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when STAA's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.